December 2011

NeMoDevices receives funding within the national framework of measures against the strong swiss franc. The project "A new multi-parameter neuromonitoring system to save patients` lives in stroke, brain injury, cardiac arrest and sleep apnea" submitted by together with ETH Zurich and two industrial partners is supported by CTI with 438kCHFr. The project will start January 2012 and last for 18 Month.

August 2011

NeMoDevices receives Eurostars funding. The project "Opto-Brain" submitted together with partners in Switzerland, Germany and Austria was ranked amongst the top five percent of almost 350 submitted projects in Europe. The project has an overall budget of 2.5 millions and allows NeMoDevices to refine the already existing prototype of the NeMoSystem and to finalize it for the market entry. A press release issued by accelopment AG the company in charge of the management of the project is available here (in German) .

June 2011

NeMoDevices receives the Swiss Quality Award in the technology category from the Swiss Medical Association (FMH). A portrait of the winner project has been published in the Swiss doctor's journal. The filed paper explaining the approach with optical technologies for combined monitoring of cerebral blood flow and oxygen metabolism to improve outcome in patients with stroke, traumatic brain injury and after cardiac arrest can be found here.

December 2010

A new paper on «Neuromonitoring in Intensive Care» has been published by members of the NeMo team. The publication titled «Neuromonitoring in Intensive Care: A New Brain Tissue Probe for Combined Monitoring of Intracranial Pressure (ICP) Cerebral Blood Flow (CBF) and Oxygenation» reports on clinical results with the NeMo Probe.

November 2010

In collaboration with the Mayo Clinic in Jacksonville, NeMoDevices has filed an FDA submission for Investigational Device Exemption (Pre-IDE). This submission is part of the research collaboration of the two organization. Together with the Mayo Clinic, NeMoDevices is setting up a phase II study involving the first use of the NeMo System in the U.S.

October 2010

October 29, 2010 is World Stroke Day.
Please check out the website of the World Stroke Campaign for more information.

May 2010

NeMoDevices has been elected into the «Swiss start-up team» 2010. This great success is rewarded with a unique entrepreneurial development program bringing together a total of 20 highly promising high-tech entrepreneurial participants. These winners of «venture leaders» will be flying to Boston in June 2010 to grow their entrepreneurship skills.
“venture leaders” is offered by «venturelab», the startup training programme of the Innovation Promotion Agency CTI, in close collaboration with the international Entrepreneur Of The Year® award by Ernst&Young and Swissnex Boston.

April 2010

This month NeMoDevices has successfully completed a financing round funded by the VELUX STIFTUNG. The financing will be used over the next two years to further advance NeMoDevices's technology in the area of non invasive monitoring of cerebral blood flow and oxygenation and to perform a clinical study with the NeMo Patch product in 2011.
This will enable NeMoDevices to establish a stronger position with its monitoring devices and to make significant progress in pushing them towards serial production.

March 2010

NeMoDevices is currently building up a research collaboration with M.D. William D. Freeman of the Mayo Clinic in Jacksonville, FL. The two partners are working together to set up a phase II study involving the first use of the NeMo System in the U.S.

October & November 2009

Results of first prototype tests were communicated at the scientific meetings 10th International Conference on Cerebral Vasospasm in Chongqing, China and at the 9th International Conference on Cerebral Surgery in Nagoya, Japan.

October 2009

Submission of 1st scientific publication entitled “Neuromonitoring in Intensive Care: A New Brain Tissue Probe for Combined Monitoring of Intracranial Pressure (ICP) Cerebral Blood Flow (CBF) and Oxygenation” in the journal Acta Neurochirurgica.

September 2009

The research group of the Neurointensive Care Unit, University Hospital Zürich was awarded a grant by the Swiss National Science Foundation to perform the clinical studies with the NeMo Probe.

June 2009

On June 2nd and 9th, the application of two next prototypes of the NeMo Probe provided a breakthrough in brain monitoring and the history of NeMoDevices. For the very 1st time brain blood flow, oxygen, temperature and pressure could be measured within the brain tissue with one single device. The proof of principle of the NeMo System could be shown.

December 2008

On December 21th, the first prototype of the NeMo Probe could be successfully applied in a patient at the Neurointensive Care Unit of the University Hospital Zürich.

October 2008

NeMoDevices being the industrial partner in the project, the University and ETH Zürich is awarded a grant by CTI (Swiss Confederation`s innovation agency).

September 2008

On September 9, 2008 the Commission for Technology and Innovation (CTI) of Switzerland awarded NeMoDevices AG with the CTI Label.

May 2008

On May 7, 2008 NeMoDevices achieved the 2nd price of venture08 business plan competition (www.venture.ch).

March 2008

On March 18, 2008, NeMoDevices was awarded the ZKB Pionierpreis TECHNOPARK®

January 2008

1st posterprize scientific meeting EuroNeuro 08 in Maastricht for a scientific contribution of the Neurointensive Care Unit, University Hospital Zürich with the contribution "Bedside Cerebral Blood Flow Monitoring in Patients with Aneurysmal Subarachnoid Hemorrhage"

November 2007

NeModevices was granted a loan by the Volkswirtschaftsstiftung Zürich

February 2007

Foundation of NeMoDevices AG as a spin-off company from the University and ETH Zurich.